Bio Digital Artificial Intelligence
High-Throughput Vaccine Production: The Future of Scalable, Rapid Immunisation
Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...
November 10, 2025 | Analysis
Lumonus Raises A$25 Million Series B to Accelerate Global Adoption of Its AI-Powered Oncology Workflow Platform
Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The roun...
November 10, 2025 | News
Harbour BioMed and Evinova Partner to Drive AI-Enabled Biologics Development
Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel anti...
November 10, 2025 | News
Lunit Showcases AI-Powered Digital Pathology Breakthroughs at SITC 2025
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-...
November 10, 2025 | News
Ailux and Eli Lilly Forge $345 Million AI-Driven Collaboration to Accelerate Bispecific Antibody Discovery
Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a stra...
November 06, 2025 | News
Thermo Fisher to Acquire Clario for US$8.9 Billion to Expand Digital and AI-Driven Clinical Trial Capabilities
Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margin ...
October 30, 2025 | News
Harbour BioMed Unveils Generative AI HCAb Model to Redefine Antibody Discovery and Development
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immu...
October 29, 2025 | News
Pharmaron to Acquire Majority Stake in Biortus Biosciences to Strengthen Structural Biology and AI-Driven Drug Discovery Capabilities
Pharmaron Beijing Co., Limited announced that it has entered into a definitive Share Purchase Agreement to acquire 82.54% equity interest of Biortus ...
October 29, 2025 | News
Swiss Rockets Secures Global License for MGI CoolMPS Sequencing Platform to Advance Multi-Omics Innovation
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced that they entered into a exclusive license agreement with MGI Tech and Complete Genomi...
October 29, 2025 | News
METiS TechBio’s AI-Designed MTS-004 Meets Phase III Success in China, Targeting Pseudobulbar Affect
MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar Affect (PBA) METiS TechBio, a global leader in AI-driven nanodelivery and formulatio...
October 24, 2025 | News
10x Genomics and Anthropic Partner to Bring Conversational AI to Single Cell and Spatial Biology
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making adva...
October 21, 2025 | News
A.D.A.M. Innovations and SOPHiA GENETICS Partner to Advance AI-Driven Liquid Biopsy Cancer Testing in Japan
A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS , an AI technology company pioneering data-d...
October 17, 2025 | News
Thermo Fisher Partners with OpenAI to Accelerate Drug Development through Artificial Intelligence
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s pro...
October 17, 2025 | News
Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems
Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...
October 15, 2025 | Interview
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
